this way only, and it broadens it to give a lot of opportunity to people that don t come from communities or don t come from backgrounds that may be adept to that i know you re speaking at our national action network convention next month, in a couple weeks, and randi is too tell us the importance of understanding communities that are not always geared toward what we have seen as a one-dimensional, everybody has to be this, or that s the definition of success. there are different levels of being successful, and we have to have people being able to train them in that way. absolutely. look, the president is reshaping the economy with the chips and science act, with the infrastructure plan, with the climate provisions of the inflation reduction act. we want to see a reimagination of our pipeline programs over career and college programming, pathway programming.
demand thousands of critically trained workers that we simply don t have this to me makes perfect sense but i thought the perkins act provided a whole lot of money to high school-aged kids to do this cool-to-work pipeline. is it not adequate what is this money going to do that perkins doesn t do? so we have a really fractured school-to-work pipeline, and part of what the secretary is doing so a couple weeks ago i was on morning joe with gina romando, the secretary of commerce, about how they re using the new chips money to try to leverage school-to-work pipeline programs as well. here i think what secretary is doing is really important because one of the key problems, we have huge shortages schools are the front lines to
Prioritizing the development of EO-3021, a potential best-in-class ADC targeting Claudin18.2, and additional pipeline programs including those through its.
Elevation Oncology (ELEV) Announces Pipeline Prioritization, Realignment of Resources to Advance EO-3021 and CEO Transition streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
During the event, the Company plans to showcase its R&D progress and platform innovation, as well as its product and pipeline goals for 2023 focused on continued commercial execution of four RNAi therapeutic products, and advancement of early-, mid-, and late-stage investigational programs.